Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 5/2007

01-05-2007 | Letter to the Editor

Calcium-PTH-vitamin D axis in older patients with hip fracture

Authors: A. A. Fisher, M. W. Davis

Published in: Osteoporosis International | Issue 5/2007

Login to get access

Excerpt

We read with interest the article by Sakuma and colleagues [1] dealing with the controversial issue of vitamin D-PTH status in hip fracture (HF) patients. With an ageing population and exponentially increasing numbers of HFs worldwide, it is important to clarify the contribution of abnormalities in calcium-PTH-vitamin D relationships to HFs. Adequate vitamin D-PTH status is paramount in calcium homeostasis and for bone health. However, recent large randomised controlled trials [2‐4] as well as systemic reviews [5‐7] contrary to a previous meta-analysis [8] did not find that supplementation with vitamin D and calcium reduces HFs, except in frail people confined to institutions [7]. …
Literature
1.
Sakuma M, Endo N, Oinuma T et al (2006) Vitamin D and intact PTH status in patients with hip fracture. Osteoporosis Int 17:1608–1614CrossRef
2.
Grant AM, Avenell A, Campbell MK et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621–1628PubMedCrossRef
3.
Porthouse J, Cockayne S, King C et al (2005) Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330:1003PubMedCrossRef
4.
Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683PubMedCrossRef
5.
Gillespie LD, Gillespie WJ, Robertson MC et al (2003) Interventions for preventing falls in elderly people. Cochrane Database Syst Rev CD000340
6.
Latham NK, Anderson CS, Reid IR (2003) Effects of vitamin D supplementation on strength, physical performance and falls in older persons: a systematic review. J Am Geriatr Soc 51:1219–1226PubMedCrossRef
7.
Avenell A, Gillespie WJ, Gillespie LD et al (2005) Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 20:CD000227
8.
Bischoff-Ferrari HA, Willett WC, Wong JB et al (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomised controlled trials. JAMA 293:2257–2264PubMedCrossRef
9.
Heaney RP (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 80:1706S–1709SPubMed
10.
Moniz C, Dew T, Dixon T (2005) Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin 21:1891–1894PubMedCrossRef
11.
Dixon T, Mitchell P, Beringer T et al (2006) An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin 22:405–415PubMedCrossRef
12.
Sahota O, Gaynor K, Harwood RH et al (2001) Hypovitaminosis D and “functional hypoparathyroidism”- the NoNoF (Nottingham Neck of Femur) study. Age Ageing 30:467–472PubMedCrossRef
13.
Sahota O, Mundey MK, San P et al (2004) The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover and bone mineral density in postmenopausal women with established osteoporosis. Bone 35:312–319PubMedCrossRef
14.
Lips P (2001) Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477–501PubMedCrossRef
15.
Saleh F, Jorde R, Sundsfjord J et al (2006) Causes of secondary hyperparathyroidism in a healthy population: the Tromso study. J Bone Miner Metab 24:58–64PubMedCrossRef
16.
Silver J, Levi R (2005) Cellular and molecular mechanisms of secondary hyperparathyroidism. Clin Nephrol 63:119–126PubMed
17.
Sahota O, Mundey MK, San P et al (2006) Vitamin D insufficiency and the blunted PTH response in established osteoporosis: the role of magnesium deficiency. Osteoporos Int 17:1013–1021PubMedCrossRef
18.
Delmas PD, Eastell R, Garnero P et al (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11:S2–S17PubMedCrossRef
19.
Iki M, Morita A, Ikeda Y et al (2006) Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women - the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 17:1086–1095PubMedCrossRef
20.
Sambrook PN, Chen CJ, March L et al (2006) High bone turnover is an independent predictor of mortality in the frail elderly. J Bone Miner Res 21:549–555PubMedCrossRef
21.
von Muhlen DG, Greendale GA, Garland CF et al (2005) Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int 16:1721–1726CrossRef
Metadata
Title
Calcium-PTH-vitamin D axis in older patients with hip fracture
Authors
A. A. Fisher
M. W. Davis
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 5/2007
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-006-0284-x

Other articles of this Issue 5/2007

Osteoporosis International 5/2007 Go to the issue

Original Article

The clinical utility of measured kyphosis as a predictor of the presence of vertebral deformities

Editorial

Unmet needs in fracture prevention: new European guidelines for the investigation and registration of therapeutic agents

Letter to the Editor

Reply to Fisher et al.: Calcium-PTH-vitamin D axis in older patients with hip fracture

Letter

Comment on Schott et al.: Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model

Review

The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis

Original Article

Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound